Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
AHEAD
AddedJun 20, 2026
UpdatedJun 20, 2026
AHEAD

AHEAD

AHEAD Medicine builds AI software that automates flow cytometry analysis for clinical diagnostics and cell therapy quality control.

HQ
San Jose, CA, US
Founded
2017
Overview
Analysis
Compare
Employees
News

AHEAD Medicine is a healthcare technology company that develops artificial intelligence software for automating flow cytometry data analysis. Its platform supports disease diagnosis, patient monitoring, and cell therapy quality control applications.

Founded in 2017, the company operates from San Jose, California, with a focus on improving efficiency and consistency in complex cellular data interpretation.

AHEAD - Products & Services

  • Cyto-copilot logo

    Cyto-copilot

    Cyto-copilot is an AI platform that automates flow cytometry analysis for clinical diagnostics, disease monitoring, and cell therapy quality control.

AHEAD - Similar Companies

Ahead Project logo

Ahead Project

AIxMed logo

AIxMed

aixmed.com

Autonomous Healthcare logo

Autonomous Healthcare

AZmed logo

AZmed

azmed.co

Adonis logo

Adonis

adonis.io

Akasa logo

Akasa

akasa.com

Caire Health logo

Caire Health

cairehealth.com

ChestAi logo

ChestAi

Aqtual logo

Aqtual

aqtual.com

Helio Health logo

Helio Health

heliohealth.com

Foresee Medical logo

Foresee Medical

foreseemed.com

Hippocratic AI logo

Hippocratic AI

hippocraticai.com

Heads Up Health logo

Heads Up Health

headsuphealth.com

Axiom Health logo

Axiom Health

axiomhealth.com

Moonlight AI logo

Moonlight AI

moonlight-ai.com

AHEAD - Quick Facts

Who are AHEAD's competitors?

Companies similar to AHEAD include Ahead Project, AIxMed, Autonomous Healthcare and AZmed.

When was AHEAD founded?

AHEAD was founded in 2017.

Where is AHEAD's headquarters located?

AHEAD's headquarters is located in San Jose, CA, US.

AHEAD - Classification

Industry
  • Medical Software
Technology
  • Machine Learning
Model
  • Software
Revenue
  • SaaS
Customer
  • Enterprise
Tags
  • Healthtech